Authentikos Wealth Advisory’s Renalytix plc American Depositary Shares RNLX Stock Holding History
Bought
Maintained
Sold
Other funds holding RNLX
CH
GGHC
PA
PCM
TC
GIM
Authentikos Wealth Advisory's RNLX Position: Q4 2023 in Review
Authentikos Wealth Advisory sold out of Renalytix plc American Depositary Shares (RNLX) in Q4 2023, closing a stake of 70 shares — an estimated $112 sold.
Authentikos Wealth Advisory first reported a position in RNLX in Q3 2023 and held it in 1 quarter. The position peaked at $112 in Q3 2023. 27 funds tracked by Wall St. Rank hold RNLX as of Q4 2023.
- Authentikos Wealth Advisory reported no remaining Renalytix plc American Depositary Shares position as of Q4 2023 after selling out during the quarter.
- Authentikos Wealth Advisory sold 70 Renalytix plc American Depositary Shares shares in Q4 2023, an estimated $112.
- Authentikos Wealth Advisory first reported a position in Renalytix plc American Depositary Shares in Q3 2023 and held it in 1 quarter.
- Authentikos Wealth Advisory's Renalytix plc American Depositary Shares position peaked at $112 in Q3 2023.
- 27 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2023.
Based on Authentikos Wealth Advisory's 13F filing for Q4 2023, filed 30 Jan 2024.